Martin Levinson
Pediatrics · Bingham Farms, MINPI 1346358967
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 222 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 14.0% — the pattern of someone who eats at a lot of different presentations. Among pediatrics clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 222 payments — averaging $18.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironshore Pharmaceuticals Inc.$571
- Corium, LLC$506
- GSK$358
- Alk-abello, Inc$279
- Supernus Pharmaceuticals, Inc.$258
- Tris Pharma Inc$257
- plus $2K from 19 others
Across 137 payments — averaging $3933.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$341K
- GSK$110K
- AbbVie$88K
What the payments were for
- Food & beverage$4,066100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ironshore Pharmaceuticals Inc. | 24 | $571 |
| Corium, LLC | 39 | $506 |
| GSK | 15 | $358 |
| Alk-abello, Inc | 16 | $279 |
| Supernus Pharmaceuticals, Inc. | 9 | $258 |
| Tris Pharma Inc | 18 | $257 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $251 |
| Pfizer | 18 | $228 |
| Collegium Pharmaceutical, Inc. | 5 | $215 |
| Merck | 11 | $157 |
| Sanofi Pasteur Inc. | 9 | $144 |
| Cranial Technologies, Inc | 8 | $136 |
| Noven Pharmaceuticals, Inc. | 1 | $125 |
| Neos Therapeutics, LP | 6 | $97 |
| Adlon Therapeutics L.p. | 6 | $89 |
| Sobi, Inc | 4 | $72 |
| Sanofi-aventis U.S. LLC | 3 | $66 |
| Verrica Pharmaceuticals Inc. | 3 | $55 |
| Seqirus USA Inc | 3 | $52 |
| Kaleo, Inc. | 2 | $35 |
| Shire North American Group Inc | 2 | $26 |
| Genentech USA, Inc. | 2 | $26 |
| Ironwood Pharmaceuticals, Inc | 1 | $25 |
| Biomarin Pharmaceutical Inc. | 1 | $23 |
| Noven Therapeutics, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$132
- Xelstrym$125
- JORNAY PM$125
- Jornay PM 20mg capsules (Bottle of 100)$111
How this compares
$4,066 in reported general payments places this provider in the 95th percentile of 1,473 pediatrics providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 21 | $542 |
| Fluvoxamine Maleate | 22 | $376 |
| Lamotrigine | 11 | $240 |
| Metoprolol Tartrate | 11 | $93 |
| Atorvastatin Calcium | 21 | $89 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 11 | $53 |
| Esomeprazole Magnesium | 13 | $35 |
| Carvedilol | 12 | $25 |
| Escitalopram Oxalate | 13 | $21 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Bingham Farms
- Roger SilversteinBingham Farms$4K
- Rickey WilsonCaledonia$263K
- Meera ChitlurDetroit$236K
- Randall LejaGrand Rapids$211K
- Madhvi RajpurkarDetroit$162K
- Wanda Whitten-ShurneyDetroit$152K
- Brian LecleirGrand Rapids$145K
- Jeanette CampbellPontiac$94K
- David SvilarAnn Arbor$66K
- Marcus DegrawDetroit$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.